Panbela Therapeutics, Inc. (PBLA) Earnings
|
Expand Research on PBLA
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +11.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -16.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/14/24 | Q324 | -$1.48 | $0.00 | -$1.48 | N/A | N/A | N/A |  | | Details | |
11/14/24  |
Q324 | N/A | -$15.00 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/13/24 | Q224 | -$1.47 | $0.00 | -$1.47 | N/A | N/A | N/A | | | Details | |
| 5/15/23 | Q123 | -$2.28 | -$3.60 | +$1.32 | N/A | N/A | N/A | | | Details | |
| 3/23/23 | Q422 | N/A | -$3.60 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/10/22 | Q322 | -$0.21 | -$0.23 | +$0.02 | N/A | N/A | N/A | | | Details | |
| 8/15/22 | Q222 | -$1.51 | -$0.26 | -$1.25 | N/A | $-220000000000 | N/A | | | Details |
